Welcome!
Vertex Pharmaceuticals
Global review
Our 2021 portfolio performed decently
The Edge Singapore’s 2021 global portfolio returned 13.1% for the period of Feb 18, 2021, to Jan 26, 2022.
January 28, 2022
Investing ideas
Mid-year review: How The Edge Singapore's top 10 global stock picks fared
At the mid-year mark, our portfolio of 10 global stock picks for this year is up by a quarter.
August 19, 2021
Investing ideas
The STI beats us but we beat the rest
The top performer was Ted Baker with a whopping 74.9% gain while the worst performer was CrowdStrike Holdings with a 12.8% loss.
May 07, 2021
Stocks To Watch
Vertex Pharmaceuticals: Dominant moat, strong pipeline
Specialist in cystic fibrosis medication plans to raise growth potential with expanding portfolio.
February 19, 2021